Hosted on MSN2h
Alzheimer's disease could be stopped in its tracks by new drug with potential to 'prevent progression'This drug has the potential to be more targeted than others currently being studied, and we hope it will result in fewer ...
A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
ScienceAlert on MSN15h
Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to Suppress Toxic TanglesThe drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
When most people think of dementia, including Alzheimer's disease, they probably think of memory loss first. But dementia ...
“This research is taking promising steps towards a new one-of-a-kind therapy which targets tau, a damaging protein in the ...
Researchers have discovered that disruptions in the brain’s salience network, often tied to tau protein buildup, correlate strongly with behavioral changes in people with early-stage dementia.
AG03, developed by researchers at the University of Southampton, targets two critical regions of the tau protein linked to ...
DEPTAC. Based on PROTACs, or protein-targeting chimeras, D20, a dephosphorylation-targeting chimera, delivers PP1 to tau. The C-terminal tail (gray) helps the construct enter cells. [Courtesy of Xiao ...
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
When most people think of dementia, particularly Alzheimer’s disease, they often think of memory loss first. However, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback